Health Care Select Sector SPDR Fund
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
22% more first-time investments, than exits
New positions opened: 214 | Existing positions closed: 176
0% more funds holding
Funds holding: 1,716 [Q3] → 1,722 (+6) [Q4]
6% less repeat investments, than reductions
Existing positions increased: 610 | Existing positions reduced: 651
1.82% less ownership
Funds ownership: 73.27% [Q3] → 71.45% (-1.82%) [Q4]
7% less capital invested
Capital invested by funds: $30.6B [Q3] → $28.3B (-$2.29B) [Q4]
27% less call options, than puts
Call options by funds: $1.92B | Put options by funds: $2.62B
27% less funds holding in top 10
Funds holding in top 10: 112 [Q3] → 82 (-30) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for XLV.
Financial journalist opinion
Based on 14 articles about XLV published over the past 30 days
Negative
Market Watch
1 day ago
Trump is right about drug prices. He's just going about it all wrong.
The stock market doesn't believe the president about prescription drugs.

Neutral
CNBC Television
2 days ago
Final Trade: BABA, JPM, XLV, JBLU
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Neutral
CNBC Television
2 days ago
President Trump's EO to lower drug prices is the beginning of a long process, says Jeff Jonas
Jeff Jonas, Gabelli Funds portfolio manager, joins CNBC's 'Power Lunch' to discuss reactions to President Trump's executive order to lower drug prices, the impact to pharma companies, and more.

Neutral
Seeking Alpha
2 days ago
XLV: Trump's Drug Price Talk Revives Old Headlines, Not New Risks
The current market environment is the best I've seen in 30+ years, driven by risk management, blending technical and quantitative analysis, and ignoring most headlines. XLV, the Healthcare Sector SPDR ETF, exemplifies the volatile, politically influenced market, making it a challenging yet opportunistic investment landscape. Traditional investment strategies are outdated; focus on price trends, sentiment, and short-term gains rather than long-term holds and fundamental metrics.

Neutral
CNBC Television
5 days ago
StemPoint's Michelle Ross breaks down navigating the pharmaceutical sector volatility
Michelle Ross, StemPoint Capital CIO, joins 'Closing Bell' to discuss health care's weak week and how to navigate pharma volatility.

Positive
Seeking Alpha
5 days ago
Defensive Sectors Continue To Lead U.S. Stock Market This Year
President Trump announced a US-UK trade deal yesterday, which may be an early sign of a thaw in the global trade war. Although the broad US stock market has rebounded sharply in recent weeks, the recovery has yet to reverse a wide lead for defensive equities.

Positive
Zacks Investment Research
1 week ago
Upbeat April Jobs Data Put Focus on 3 Sector ETFs & Stocks
The U.S. economy added 177,000 jobs in April 2025, a slowdown from the downwardly revised 185,000 in March, but significantly surpassing market expectations of 130,000.

Neutral
MarketBeat
1 week ago
Top 3 Sectors Where Valuations Are Most Below Market Levels
Whether focusing on growth stocks, value stocks, or a mix, the goal is the same: find and invest in undervalued assets. This thread remains true when considering how to invest across the 11 different stock market sectors.

Negative
The Motley Fool
1 week ago
Invest in These ETFs to Prepare Your Portfolio for a Recession
The latest financial data, and the lack of confidence from management through earnings so far, points to the growing possibility that the U.S. economy could fall into a recession. With that being said, you want your portfolio to be prepared to keep you from losing huge sums of money.

Neutral
CNBC Television
2 weeks ago
Final Trade: SBUX, META, XLV and BABA
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Charts implemented using Lightweight Charts™